The emerging therapy of this peptide represents a significant development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – leading to https://tirzepatide-peptide002805.blogoxo.com/42473418/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment